Angiotensin II-dependent down-regulation of vascular natriuretic peptide type C receptor gene expression in hypertensive rats

Endocrinology

Volumn 137, Issue 3, 1996, Pages 1102-1107

  Yoshimoto, Takanobu ^a   Naruse, Mitsuhide ^a   Naruse, Kiyoko ^a   Shionoya, Kiseko ^a   Tanaka, Masami ^a   Tanabe, Akiyo ^a   Hagiwara, Hiromi ^b   Hirose, Shigehisa ^b   Muraki, Takamura ^a   Demura, Hiroshi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CANDESARTAN HEXETIL; MANIDIPINE; MESSENGER RNA; NATRIURETIC FACTOR; NATRIURETIC PEPTIDE RECEPTOR; NATRIURETIC PEPTIDE TYPE C; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; CONTROLLED STUDY; HORMONE RECEPTOR INTERACTION; HYPERTENSION; MALE; NATRIURESIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR UPREGULATION; SMOOTH MUSCLE FIBER; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 9044246056     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.3.8603580     Document Type: Article

References (35)

1. Rosenzweig A, Seidman CE 1991 Atrial natriuretic factor and related peptide hormones. Annu Rev Biochem 60:229-255
2. Maack T 1992 Receptors of atrial natriuretic factor. Annu Rev Physiol 54:11-27
3. Suga S, Nakao K, Itoh H, Komatsu Y, Ogawa Y, Hama N, Imura H 1992 Endotherial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-b. J Clin Invest 90:1145-1149
4. Furuya M, Aisaka K, Miyazaki T, Honbou M, Kawashima K, Ohno T, Tanaka S, Minamino N, Kangawa K, Matsuo H 1993 C-type natriuretic peptide inhibits intimai thickening after vascular injury. Biochem Biophys Res Commun 193:248-253
5. Chinkers M, Garbers DL, Chang MS, Lowe DG, Chin H, Goeddel DV, Schulz S 1989 A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature 338:78-83
6. Schulz S, Singh S, Bellet RA, Singh G, Tubb DJ, Chin H, Garbers DL 1989 The primary stracture of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family. Cell 58:1155-1162
7. Maack T, Suzuki M, Almedia FA, Nussenzveig D, Scarborough RM, McEnroe GA, Lewicki JA 1987 Physiological role of silent receptors of atrial natriuretic factor. Science 238:675-678
8. Suga S, Nakao K, Kishimoto I, Hosoda K, Mukoyama M, Ogawa Y, Shirakami G, Arai H, Saito Y, Kambayashi Y, Inoue K, Imura H 1992 Receptor selectivity of natriuretic peptide family, Aatrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 130:229-239
9. Laragh JH 1985 Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolytes homeostasis. N Engl J Med 313:1330-1340
10. Yoshimoto T, Naruse M, Naruse K, Fujimaki Y, Tanabe A, Muraki T, Itakura M, Hagiwara H, Hirose S, Demura H 1995 Modulation of vascular natriuretic peptide receptor gene expression in hypertensive and obese hyperglycemic rats. Endocrinology 136:2427-2434
11. Anand-Srivastava MB, Sairam MR, Cantin M 1990 Ring-deleted analogs of atrial natriuretic factor inhibit adenylate cyclase/cAMP system. J Biol Chem 265:8566-8572
12. Hu RM, Levin ER, Pedram A, Frank HJL 1992 Atrial natriuretic peptide inhibits the production and secretion of endothelin from cultured endothelial cell. J Biol Chem 267:17384-17389
13. Levin ER 1993 Natriuretic peptide C-receptor: more than a clearance receptor. Am J Physiol 264:E483-E489
14. Levin ER, Frank HJ 1991 Natriuretic peptides inhibit rat astroglial proliferation: mediation by C receptor. Am J Physiol 261:R453-R457
15. 2+ conductance and reduces cellular cAMP via a cGMP independent mechanism. Am J Physiol 263: C334-C342
16. Kubo K, Kohora Y, Yoshimura Y, Inada Y, Shibouta Y, Furukawa Y, Kato T, Nishikawa K, Naka T 1993 Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of potential prodrugs of benzimidazole-7-carboxylic acids. J Medicinal Chem 36:2343-2349
17. Nishikawa K, Inada Y, Shibouta Y, Wada Y, Ojima M, Kubo K, Naka T 1994 Pharmacological profile of a novel nonpeptide angiotensin II subtype 1 receptor antagonist, TCV-116. Blood Pressure [Suppl] 5:7-14
18. Nabika T, Nara Y, Ikeda K, Endo J, Yamori Y 1991 Genetic heterogeneity of the spontaneously hypertensive rats between the different sources. Hypertension 18:12-16
19. Ross R 1971 The smooth muscle cell: II. Growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol 50:172-186
20. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
21. Fuller F, Porter JG, Arfsten AE, Miller J, Schilling JW, Scarborough RM, Lewicki JA, Schenk DB 1988 Atrial natriuretic peptide clearance receptor. J Biol Chem 263:9395-9401
22. Schiffrin EL, Turgeon A, Tremblay J, Deslongchamps M 1991 Effects of ANP, angiotensin, vasopressin, and endothelin on ANP receptors in cultured rat vascular smooth muscle cells. Am J Physiol 260:H58-H65
23. Chabrier PE, Roubert P, Lonchampt MO, Plas P, Braquet P 1988 Regulation of atrial natriuretic factor receptors by angiotensin II in rat vascular smooth muscle cells. J Biol Chem 263:13199-13202
24. Shibota M, Nagaoka A, Shino A, Fujita T 1979 Renin-angiotensin system in stroke-prone spontaneously hypertensive rats. Am J Physiol 236:H409-H416
25. Yoshimoto T, Naruse M, Tanabe A, Naruse K, Takagi K, Muraki T, Itakura M, Hagiwara H, Hirose H, Demura H 1994 Angiotensin converting enzyme inhibitor but not calcium blocker down-regulates gene expression of vascular natriuretic peptide receptor in hypertensive rats. Biochem Biophys Res Commun 205:1595-1600
26. Uchida K, Mizuno T, Shimonaka M, Sugiura N, Hagiwara H, Hirose S 1989 Subtype switching of ANP receptors during in vitro culture of vascular cells. Am J Physiol 256:H311-H314
27. Suga S, Nakao K, Kishimoto I, Hosoda K, Mukoyama M, Arai H, Shirakami G, Ogawa Y, komatu Y, Nakagawa O, Hama N, Imura H 1992 Phenotype-related alteration in expression of natriuretic peptide receptors in aortic smooth muscle cells. Circ Res 71:34-39
28. Kato J, Lanier-Smith K L, Currie M G 1991 Cyclic GMP down-regulates atrial natriuretic peptide receptors on cultured vascular endothelial cells. J Biol Chem 266:14681-14685
29. Kishimoto I, Nakao K, Suga S, Hosoda K, Yoshimasa T, Itoh H, Imura H 1993 Downregulation of C-receptor by natriuretic peptides via ANP-B receptor in vascular smooth muscle cells. Am J Physiol 265:H1373-H1379
30. Wei CM, Kim CH, Khraibi AA, Miller VM, Bunnet JC Jr 1994 Atrial natriuretic peptide and C-type natriuretic peptide in spontaneously hypertensive rats and their vasorelaxing actions in vitro. Hypertension 23:903-907
31. Schiffrin EL, St-Louis J 1987 Decreased density of vascular receptors for atrial natriuretic peptide in DOCA-salt hypertensive rats. Hypertension 9:504-512
32. Morii N, Nakao K, Kihara M, Sugawara A, Sakamoto M, Yamori Y, Imura H 1986 Decreased content in left atrium and increased plasma concentration of atrial natriuretic polypeptide in spontanepusly hypertensive rats (SHR) and SHR stroke-prone. Biochem Biophys Res Commun 135:74-81
33. Kohno M, Horio T, yoshiyama M, Takeda T 1992 Accelerated secretion of brain natriuretic peptide from the hypertrophied ventricles on experimental malignant hypertension. Hypertension 19: 206-211
34. Magg J, Marttila M, Mantymaa P, Vuolteenaho O 1994 Brain natriuretic peptide in plasma, atria, and ventricles of vasopressin-and phenylephrine-infused conscious rats. Endocrinology 134:2505-2515
35. Brown LA, Nunez DJR, Wilkins MR 1993 Differential regulation of natriuretic peptide receptor messenger RNAs during the development of cardiac hypertrophy in the rat. J Clin Invest 92:2702-2712